Suppr超能文献

原发性晚期卵巢癌的腹腔镜肿瘤细胞减灭术

Laparoscopic cytoreduction for primary advanced ovarian cancer.

作者信息

Fanning James, Hojat Rod, Johnson Jil, Fenton Bradford

机构信息

Summa Health System, Northeastern Ohio Universities College of Medicine, Akron, Ohio 44304, USA.

出版信息

JSLS. 2010 Jan-Mar;14(1):80-2. doi: 10.4293/108680810X12674612014707.

Abstract

INTRODUCTION

We evaluated the feasibility of laparoscopic cytoreduction for primary advanced ovarian cancer.

METHODS

All patients with presumed stage 3/4 primary ovarian cancer underwent attempted laparoscopic cytoreduction. All patients had CT evidence of omental metastasis and ascites. A 5-port (5-mm) transperitoneal approach was used. A bilateral salpingo-oophorectomy, supracervical hysterectomy, and omentectomy were performed with PlasmaKinetic (PK) cutting forceps. A laparoscopic 5-mm Argon-Beam Coagulator was used to coagulate tumor in the pelvis, abdominal peritoneum, intestinal mesentery, and diaphragm.

RESULTS

Nine of 11 cases (82%) were successfully debulked laparoscopically without conversion to laparotomy. Median operative time was 2.5 hours, and median blood loss was 275 mL. All tumors were debulked to <2 cm and 45% had no residual disease. Stages were 1-3B, 7-3C, and 1-4. Median length of stay was one day. Median VAS pain score was 4 (discomforting). Two of 11 patients (18%) had postoperative complications.

CONCLUSION

Laparoscopic cytoreduction was successful and resulted in minimal morbidity. Because of our small sample size, additional studies are needed.

摘要

引言

我们评估了腹腔镜细胞减灭术治疗原发性晚期卵巢癌的可行性。

方法

所有疑似3/4期原发性卵巢癌患者均尝试接受了腹腔镜细胞减灭术。所有患者均有CT证据显示存在大网膜转移和腹水。采用五孔(5毫米)经腹入路。使用等离子动力(PK)钳进行双侧输卵管卵巢切除术、次全子宫切除术和大网膜切除术。使用腹腔镜5毫米氩束凝固器对盆腔、腹腔腹膜、肠系膜和膈肌的肿瘤进行凝固。

结果

11例患者中有9例(82%)成功通过腹腔镜实现肿瘤细胞减灭,未中转开腹。中位手术时间为2.5小时,中位失血量为275毫升。所有肿瘤均减灭至<2厘米,45%的患者无残留病灶。分期为1-3B、7-3C和1-4。中位住院时间为1天。中位视觉模拟评分(VAS)疼痛评分为4分(不适)。11例患者中有2例(18%)出现术后并发症。

结论

腹腔镜细胞减灭术取得成功,且发病率极低。由于我们的样本量较小,因此需要进一步研究。

相似文献

1
Laparoscopic cytoreduction for primary advanced ovarian cancer.
JSLS. 2010 Jan-Mar;14(1):80-2. doi: 10.4293/108680810X12674612014707.
2
Laparoscopic-assisted cytoreduction for primary advanced ovarian cancer: success, morbidity and survival.
Gynecol Oncol. 2011 Oct;123(1):47-9. doi: 10.1016/j.ygyno.2011.06.020. Epub 2011 Jul 7.
3
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.
Am J Obstet Gynecol. 2016 Apr;214(4):503.e1-503.e6. doi: 10.1016/j.ajog.2015.10.922. Epub 2015 Oct 31.
5
Single-port laparoscopic surgery for benign salpingo-ovarian pathology: a single-center experience from Saudi Arabia.
Ann Saudi Med. 2016 Jan-Feb;36(1):64-9. doi: 10.5144/0256-4947.2016.26.1.1200. Epub 2016 Jan 26.
6
Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator.
Gynecol Oncol. 2001 Oct;83(1):39-48. doi: 10.1006/gyno.2001.6344.
8
Laparoendoscopic single-site surgery (LESS) in gynecologic oncology: technique and initial report.
Gynecol Oncol. 2009 Aug;114(2):157-61. doi: 10.1016/j.ygyno.2009.05.020. Epub 2009 May 28.
9
Solo surgeon single-port laparoscopic surgery with a homemade laparoscope-anchored instrument system in benign gynecologic diseases.
J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):695-701. doi: 10.1016/j.jmig.2014.02.001. Epub 2014 Feb 6.
10
[Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Therapeutic Management of Early Stages].
Gynecol Obstet Fertil Senol. 2020 Mar;48(3):287-303. doi: 10.1016/j.gofs.2020.01.016. Epub 2020 Jan 28.

引用本文的文献

1
Extragonadal immature teratoma of the uterus.
Gynecol Oncol Rep. 2025 Feb 22;58:101707. doi: 10.1016/j.gore.2025.101707. eCollection 2025 Apr.
2
Postoperative Complications of Upfront Ovarian Cancer Surgery and Their Effects on Chemotherapy Delay.
Curr Oncol. 2024 Sep 19;31(9):5630-5642. doi: 10.3390/curroncol31090417.
3
Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer.
Front Oncol. 2024 Feb 2;14:1302724. doi: 10.3389/fonc.2024.1302724. eCollection 2024.
4
Outcomes of Laparoscopic Optimal Interval Cytoreduction Surgery (LOICS) in Patients with Advanced Ovarian Cancers Having Low Burden Disease.
Indian J Surg Oncol. 2023 Mar;14(1):270-276. doi: 10.1007/s13193-022-01682-9. Epub 2022 Nov 18.
5
Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction.
Diagnostics (Basel). 2020 Aug 7;10(8):568. doi: 10.3390/diagnostics10080568.
7
Minimally invasive hysterectomy at a university teaching hospital.
JSLS. 2014 Jul-Sep;18(3). doi: 10.4293/JSLS.2014.00231.
8
Effects of electrosurgery and vaginal closure technique on postoperative vaginal cuff dehiscence.
JSLS. 2013 Jul-Sep;17(3):414-7. doi: 10.4293/10860813X13693422518515.
9
Laparoscopic major gynecologic surgery in patients with prior laparotomy bowel resection.
JSLS. 2011 Oct-Dec;15(4):448-50. doi: 10.4293/108680811X13176785203833.

本文引用的文献

2
Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
Am J Obstet Gynecol. 2008 Dec;199(6):642.e1-6. doi: 10.1016/j.ajog.2008.06.052. Epub 2008 Sep 17.
3
Robotic radical hysterectomy.
Am J Obstet Gynecol. 2008 Jun;198(6):649.e1-4. doi: 10.1016/j.ajog.2007.11.002.
4
Feasibility of the Maylard transverse incision for ovarian cancer cytoreductive surgery.
J Minim Invasive Gynecol. 2007 May-Jun;14(3):352-5. doi: 10.1016/j.jmig.2006.11.009.
5
Surgical approach to hysterectomy for benign gynaecological disease.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD003677. doi: 10.1002/14651858.CD003677.pub2.
6
The utility of hand-assisted laparoscopy in ovarian cancer.
Gynecol Oncol. 2005 Jan;96(1):72-6. doi: 10.1016/j.ygyno.2004.09.048.
9
The role of laparoscopy in second-look evaluations for ovarian cancer.
Gynecol Oncol. 2001 Jan;80(1):44-7. doi: 10.1006/gyno.2000.6036.
10
Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?
Gynecol Oncol. 2000 Sep;78(3 Pt 1):329-35. doi: 10.1006/gyno.2000.5914.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验